Second-line FOLFOX chemotherapy for advanced biliary tract cancer - Authors' reply.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Author
Lamarca, AngelaPalmer, Daniel H
Wasan, Harpreet Singh
Ross, Paul J
Ma, Yuk Ting
Arora, Arvind
Falk, Stephen
Gillmore, Roopinder
Wadsley, Jonathan
Patel, Kinnari
Anthoney, Alan
Maraveyas, Anthony
Iveson, Tim
Waters, Justin S
Hobbs, Claire
Barber, Safia
Ryder, W David
Ramage, John
Davies, Linda M
Bridgewater, John A
Valle, Juan W
Publication date
2021-07Subject
Haematology
Metadata
Show full item recordAbstract
No abstract availableCitation
Lamarca A, Palmer DH, Wasan HS, Ross PJ, Ma YT, Arora A, Falk S, Gillmore R, Wadsley J, Patel K, Anthoney A, Maraveyas A, Iveson T, Waters JS, Hobbs C, Barber S, Ryder WD, Ramage J, Davies LM, Bridgewater JA, Valle JW; Advanced Biliary Cancer Working Group. Second-line FOLFOX chemotherapy for advanced biliary tract cancer - Authors' reply. Lancet Oncol. 2021 Jul;22(7):e288-e289. doi: 10.1016/S1470-2045(21)00341-7Type
OtherAdditional Links
http://www.sciencedirect.com/science/journal/14702045PMID
34197751Journal
The Lancet OncologyPublisher
Lancet Publishing Groupae974a485f413a2113503eed53cd6c53
10.1016/S1470-2045(21)00341-7